Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.

Journal of gastrointestinal and liver diseases : JGLD - 1 Jun 2015

Kalafateli Maria, Kourakli Alexandra, Gatselis Nikolaos, Lambropoulou Polixeni, Thomopoulos Konstantinos, Tsamandas Athanasios, Christofidou Mirto, Zachou Kalliopi, Jelastopoulou Eleni, Nikolopoulou Vasiliki, Symeonidis Argiris, Dalekos George N, Lambropoulou-Karatza Chrissoula, Triantos Christos

Abstract excerpt

BACKGROUND & AIMS: Monotherapy with standard or pegylated interferon (PegIFN) remains the first-line treatment for HCV infection in patients with thalassemia major (βTM), although its long-term impact is still unknown. We aimed to assess the efficacy of IFN-a2b/PegIFN-a2b (one or multiple treatment sessions) and the predictors for sustained virological response (SVR) in HCV-infected βTM patients. METHODS: Between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Thalassemia
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferons

Share to Interleukins

Share to Iron Chelating Agents

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Splenectomy

Source

Identifiers

PMID: 26114179
DOI: 10.15403/jgld.2014.1121.242.a2b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.PMID 26114179Read ↗

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit.Semantic proximity Read ↗

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?Semantic proximity Read ↗

Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.Semantic proximity Read ↗

The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis CSemantic proximity Read ↗

Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.Semantic proximity Read ↗

Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.Semantic proximity Read ↗

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.Semantic proximity Read ↗

The prevalence of hepatitis C virus (HCV) infection in <i>β</i>-thalassemia patients in Pakistan: a systematic review and meta-analysisSemantic proximity Read ↗

Effectiveness And Safety Of Direct Acting Antiviral Agents In Thalassaemic Patients With Chronic Hepatitis C.Semantic proximity Read ↗

Interferon λ3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.Semantic proximity Read ↗

Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia.Semantic proximity Read ↗

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.